During the past decade, Azidus Laboratories Ltd. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Azidus Laboratories Ltd." are "Bioequivalence" (5 trials) and "Therapeutic Equivalency" (1 trials). Many other conditions were trialed in "Azidus Laboratories Ltd." in a lesser frequency.

Most popular intervention types in "Azidus Laboratories Ltd." are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Diosmin/Hesperidin (90/10) 500 mg Reference Product" (1 trials), "Diosmin/Hesperidin (90/10) 500 mg Test Drug" (1 trials), "Estradiol Valerate and Dienogest 2 mg/ 2 mg Reference Product tablet" (1 trials), "Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet" (1 trials) and "Eszopiclone 3mg Reference Product Coated Tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azidus Laboratories Ltd." are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Azidus Laboratories Ltd.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Azidus Laboratories Ltd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Azidus Laboratories Ltd., 6 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".